Autonomic dysfunction in Alzheimer's disease: tools for assessment and review of the literature.

Autonomic dysfunction is very common in patients with dementia, and its presence might also help in differential diagnosis among dementia subtypes. Various central nervous system structures affected in Alzheimer's disease are also implicated in autonomic nervous system regulation, and it has been hypothesized that the deficit in central cholinergic function observed in Alzheimer's disease could likely lead to autonomic dysfunction. Several feasible tests can be used in clinical practice for the assessment of parasympathetic and sympathetic functions, especially in terms of cardiovascular autonomic modulation. In this review, we describe the different tests available and the evidence from the literature which indicate a definite presence of autonomic dysfunction in dementia at various degrees. Importantly, the recognition of dysautonomia, besides possibly being an early marker of dementia, would help prevent the disabling complications which increase the risk of morbidity, institutionalization, and mortality in these individuals.

[1]  C. Cannon,et al.  Heart failure: from bench to bedside , 2006 .

[2]  P A Low,et al.  Autonomic Nervous System Function , 1993, Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society.

[3]  Masahito Yamada,et al.  A clinical role for [123I]MIBG myocardial scintigraphy in the distinction between dementia of the Alzheimer's-type and dementia with Lewy bodies , 2001 .

[4]  Y. Schoon,et al.  Hypotensive Syndromes Are Not Associated With Cognitive Impairment in Geriatric Patients , 2013, American journal of Alzheimer's disease and other dementias.

[5]  A. Murray,et al.  Autonomic dysfunction in dementia , 2006, Journal of Neurology, Neurosurgery & Psychiatry.

[6]  P. Filardi,et al.  β-adrenergic receptors and G protein-coupled receptor kinase-2 in Alzheimer's disease: a new paradigm for prognosis and therapy? , 2013, Journal of Alzheimer's disease : JAD.

[7]  J. Idiaquez,et al.  Association between neuropsychiatric and autonomic dysfunction in Alzheimer's disease , 2002, Clinical Autonomic Research.

[8]  J. Claassen,et al.  GALANTAMINE DOES NOT CAUSE AGGRAVATED ORTHOSTATIC HYPOTENSION IN PEOPLE WITH ALZHEIMER'S DISEASE , 2010, Journal of the American Geriatrics Society.

[9]  L. F. Junqueira,et al.  Cardiac autonomic modulation and cognitive status in Alzheimer’s disease , 2010, Clinical Autonomic Research.

[10]  E. Perry,et al.  Cholinergic nicotinic and muscarinic receptors in dementia of Alzheimer, Parkinson and Lewy body types , 1990, Journal of neural transmission. Parkinson's disease and dementia section.

[11]  J. Claassen,et al.  Baroreflex function is reduced in Alzheimer’s disease: a candidate biomarker? , 2013, Neurobiology of Aging.

[12]  J. Claassen,et al.  The cerebrovascular role of the cholinergic neural system in Alzheimer's disease , 2011, Behavioural Brain Research.

[13]  E. Peskind,et al.  Hypothalamic pituitary adrenocortical and sympathetic nervous system responses to the cold pressor test in Alzheimer’s disease , 2000, Biological Psychiatry.

[14]  W. Koch,et al.  Adrenergic Nervous System in Heart Failure: Pathophysiology and Therapy , 2013, Circulation research.

[15]  B. Shahani,et al.  RR interval variation and the sympathetic skin response in the assessment of autonomic function in peripheral neuropathy. , 1990, Archives of neurology.

[16]  A R Damasio,et al.  The autonomic-related cortex: pathology in Alzheimer's disease. , 1997, Cerebral cortex.

[17]  F. Rengo,et al.  Lymphocyte G-protein-coupled receptor kinase-2 is upregulated in patients with Alzheimer's disease , 2007, Neuroscience Letters.

[18]  C. Jack,et al.  Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment , 2004, Journal of internal medicine.

[19]  Anne Corbett,et al.  Drug repositioning in Alzheimer's disease. , 2015, Frontiers in bioscience.

[20]  D. Leosco,et al.  Targeting the &bgr;-Adrenergic Receptor System Through G-Protein–Coupled Receptor Kinase 2: A New Paradigm for Therapy and Prognostic Evaluation in Heart Failure From Bench to Bedside , 2012, Circulation. Heart failure.

[21]  L. F. Junqueira,et al.  Cardiac sympathovagal modulation evaluated by short‐term heart interval variability is subtly impaired in Alzheimer's disease , 2008, Geriatrics & gerontology international.

[22]  B. Lawlor,et al.  Autonomic dysfunction in patients with dementia of the Alzheimer type , 1993, Biological Psychiatry.

[23]  D. Ewing,et al.  The Value of Cardiovascular Autonomic Function Tests: 10 Years Experience in Diabetes , 1985, Diabetes Care.

[24]  I. McKeith,et al.  The Prevalence of Autonomic Symptoms in Dementia and Their Association with Physical Activity, Activities of Daily Living and Quality of Life , 2006, Dementia and Geriatric Cognitive Disorders.

[25]  G. Román,et al.  Autonomic dysfunction in neurodegenerative dementias , 2011, Journal of the Neurological Sciences.

[26]  L Faes,et al.  Causal linear parametric model for baroreflex gain assessment in patients with recent myocardial infarction. , 2001, American journal of physiology. Heart and circulatory physiology.

[27]  Soichiro Shimizu,et al.  Comparative value of brain perfusion SPECT and [123I]MIBG myocardial scintigraphy in distinguishing between dementia with Lewy bodies and Alzheimer’s disease , 2006, European Journal of Nuclear Medicine and Molecular Imaging.

[28]  H. Braak,et al.  Staging of alzheimer's disease-related neurofibrillary changes , 1995, Neurobiology of Aging.

[29]  D. Leosco,et al.  Impact of Diabetes on Cardiac Sympathetic Innervation in Patients With Heart Failure , 2013, Diabetes Care.

[30]  K. Kojima,et al.  Autonomic dysfunctions in dementia with Lewy bodies , 2003, Journal of Neurology.

[31]  J Taki,et al.  Value of 123I-MIBG radioactivity in the differential diagnosis of DLB from AD , 2006, Neurology.

[32]  Clive Ballard,et al.  Neurocardiovascular Instability in Cognitive Impairment and Dementia , 2002, Annals of the New York Academy of Sciences.

[33]  C. Shults.  Lewy bodies. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[34]  B. Lernfelt,et al.  15-year longitudinal study of blood pressure and dementia , 1996, The Lancet.

[35]  Z. A. Wu,et al.  Cardiovascular autonomic functions in Alzheimer's disease. , 1994, Age and ageing.

[36]  B. Lawlor,et al.  Parasympathetic autonomic dysfunction is common in mild cognitive impairment , 2012, Neurobiology of Aging.

[37]  J. Claassen,et al.  Cholinergically mediated augmentation of cerebral perfusion in Alzheimer's disease and related cognitive disorders: the cholinergic-vascular hypothesis. , 2006, The journals of gerontology. Series A, Biological sciences and medical sciences.

[38]  H. Critchley.  Neural mechanisms of autonomic, affective, and cognitive integration , 2005, The Journal of comparative neurology.

[39]  F. Giubilei,et al.  Cardiac Autonomic Dysfunction in Patients with Alzheimer Disease: Possible Pathogenetic Mechanisms , 1998, Alzheimer disease and associated disorders.

[40]  Jianfeng Gao,et al.  Insular Alzheimer's disease pathology as a cause of "age-related" autonomic dysfunction and mortality in the non-demented elderly. , 2006, Medical hypotheses.

[41]  C. Iadecola.  The overlap between neurodegenerative and vascular factors in the pathogenesis of dementia , 2010, Acta Neuropathologica.

[42]  J. Claassen,et al.  Vascular Aspects of Cognitive Impairment and Dementia , 2013, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.